Hubungan Keikutsertaan Prolanis Terhadap Kepatuhan Minum Obat dan Kualitas Hidup Pasien Faskes Pertama di Kota Kendari

Restu Nur Hasanah Haris; Wa Ode Masrida; Muhamad Ramadhan Salam; Misdayanti Misdayanti; Hesti Trisnianti Burhan

doi:10.71094/vkj.v3i4.154

Authors

Restu Nur Hasanah Haris Program Studi S1 Farmasi, Institut Teknologi dan Kesehatan Avicenna, Kendari, Indonesia
Wa Ode Masrida Program Studi S1 Farmasi, Institut Teknologi dan Kesehatan Avicenna, Kendari, Indonesia
Muhamad Ramadhan Salam Program Studi S1 Farmasi, Sekolah Tinggi Kesehatan Pelita Ibu, Kendari, Indonesia
Misdayanti Program Studi Kesehatan Masyarakat, Institut Teknologi dan Kesehatan Avicenna, Kendari, Indonesia
Hesti Trisnianti Burhan Program Studi Farmasi, Universitas Khairun, Ternate, Indonesia

DOI:

https://doi.org/10.71094/vkj.v3i4.154

Keywords:

Prolanis, Compliance, Quality of Life

Abstract

This study examines the relationship between participation in the Chronic Disease Management Program (PROLANIS) and medication adherence, as well as the quality of life among patients at first-level health facilities in Kendari City. PROLANIS is an integrated health service program involving BPJS, health facilities, and patients. Medication adherence is an important factor influencing therapy success and the quality of life. This non-experimental cross-sectional study involved 480 active PROLANIS patients with hypertension and diabetes mellitus, receiving drug therapy. The research took place at the Kendari City Community Health Center from July to September 2024, using purposive sampling. Medication adherence was measured with the MARS-5 instrument, and quality of life was assessed with the SF-6D. Data analysis involved coding, scoring, and bivariate chi-square tests. Non-adherence was defined by a MARS-5 score <25, while adherence was represented by a score of 25 (maximum). A quality of life utility value of 0.00-0.78 indicated low quality, while 0.79-1.00 indicated high quality. The findings revealed that both PROLANIS and non-PROLANIS patients exhibited non-adherence (MARS-5 score <25) but reported high quality of life. Chi-square tests showed a significant relationship between PROLANIS participation and medication adherence (p-value 0.036) as well as quality of life (p-value 0.001).

Downloads

Download data is not yet available.

References

Alfiza, I. S., & Oktadiana, I. (2022). Hubungan tingkat kepatuhan pengobatan dengan keberhasilan program Prolanis pada penderita diabetes mellitus tipe 2 di UPTD Puskesmas Kroya I. Estu Utomo Health Science: Jurnal Ilmiah Kesehatan, 16(2), 14–19.

Andayani, T. M., Kristina, S. A., Endarti, D., Haris, R. N. H., & Rahmawati, A. (2020). Translation, cultural adaptation, and validation of Short-Form 6D on the general population in Indonesia. Value in Health Regional Issues, 21, 205–210.

Atto’illah, M. A., Anggraini, M. T., Lahdji, A., & Anggraheny, H. D. (2022). Keaktifan mengikuti Prolanis mempengaruhi kestabilan tekanan darah pada pasien hipertensi di Puskesmas Warungasem [Manuskrip/repository record]. Universitas Muhammadiyah Semarang.

Firdiawan, A., Andayani, T. M., & Kristina, S. A. (2021). Hubungan kepatuhan pengobatan terhadap outcome klinik pasien diabetes mellitus tipe 2 dengan Medication Adherence Rating Scale-5 (MARS-5). Majalah Farmaseutik, 17(1), 22–31.

Haris, R. N. H., Makmur, R., Andayani, T. M., & Kristina, S. A. (2019). Penilaian properti psikometrik instrumen kualitas hidup (HRQoL) pada populasi umum: Tinjauan sistematik. Jurnal Manajemen dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), 9(2).

Haris, R., Masrida, W. O., Ali, N. F. M., Idawati, Aspadiah, V., & Mahmudah, R. (2023). Tingkat kepatuhan penggunaan obat pada pasien hipertensi di instalasi rawat jalan badan layanan umum daerah (BLUD) RS Konawe. INPHARNMED, 7(1).

Jati, R. A., Muchtar, F., & Salsabila, S. (2023). Faktor risiko aktivitas fisik pada kejadian diabetes mellitus tipe 2 di wilayah kerja Puskesmas Kemaraya Kota Kendari tahun 2023. KOLONI, 2(2), 328–334.

Kristianto, F. C., Sari, D. L., & Kirtishanti, A. (2021). Pengaruh program penanggulangan penyakit kronis (PROLANIS) terhadap kadar gula darah pasien diabetes mellitus tipe 2. CoMPHI Journal: Community Medicine and Public Health of Indonesia Journal, 2(1), 8–14.

Kurniawan, G., Purwidyaningrum, I., & Herdwiani, W. (2022). Hubungan kepatuhan penggunaan obat dengan tekanan darah dan kualitas hidup peserta Prolanis hipertensi di Kabupaten Demak. Jurnal Farmasi Indonesia, 19(2), 226–235.

Larasati, N., & Husna, N. (2020). Pengaruh Prolanis dan kepatuhan minum obat terhadap tekanan darah pasien hipertensi di Puskesmas Gamping 1. Media Ilmu Kesehatan, 8(2), 87–93.

Musdalifah, M., Hamzah, W., & Baharuddin, A. (2024). Hubungan keikutsertaan kegiatan Prolanis dengan kualitas hidup lansia di wilayah kerja Puskesmas Bangkala. JUMANTIK (Jurnal Ilmiah Penelitian Kesehatan), 9(1), 92–100.

Pramana, G. A., Dianingati, R. S., & Saputri, N. E. (2019). Faktor-faktor yang mempengaruhi kepatuhan minum obat pasien hipertensi peserta Prolanis di Puskesmas Pringapus Kabupaten Semarang. Indonesian Journal of Pharmacy and Natural Product, 2(1).

Sugihen, I. K. P. G., Rengganis Wardani, D. W. S., Oktarlina, R. Z., & Carolia, N. (2022). The relationship of Prolanis participation, drug compliance and nutrition status to blood pressure control in hypertension patients in Kedaton Puskesmas, Kota Bandar Lampung. Medical Profession Journal of Lampung, 12(1), 198–205.

Tanty, H. N., Anggriani, Y., & Saragi, S. (2019). Pengaruh Prolanis terhadap outcome klinik pasien diabetes mellitus tipe 2 di Puskesmas Kecamatan Pulogadung. Farmasains: Jurnal Ilmiah Ilmu Kefarmasian, 6(1), 11–19.

Warti, L., Laksmitawati, D. R., & Sarnianto, P. (2022). Pengaruh penerapan PROLANIS pada pasien diabetes mellitus tipe 2 di Puskesmas Kota Bekasi. Jurnal Farmasi Indonesia, 19(2), 200–212.